Chronic hepatitis F7: Liver or gallbladder prolems with rib pain, contusion, gastritis and ulcers, chronic insomnia or breast distension.

1. Chronic hepatitis: 140 chronic hepatitis patients in two reports took F7 or its modification for two months and 12 were cured (8.57 percent), 32 significantly improved (22.85 percent), 51 improved (36.42 percent) and 45 did not improve (32.14 percent).

2. Gallbladder problems: 246 gall stone and infection patients took F7 for seven weeks and 75 were cured (30.48 percent), 105 significantly improved (42.68 percent), 61 improved (24.79 percent) and only 5 did not improve after treatment.

3. Chest or rib contusion: 80 patients took F7 or its modifications for up to two weeks and all were cured.

4. Chronic atrophic gastritis: 39 patients took F7 or its modification and 23 were cured (58.97 percent), 12 improved (30.76 percent) and two did not.

5. Stomach ulcer: Two studies of 30 patients showed 10 were cured (33.33 percent), 17 improved (56.66 percent) and three did not (10 percent).

6. Chronic insomnia: 30 patients took F7 for three weeks and 26 were cured (86.66 percent), 3 improved (10 percent) and one did not.

7. Breast pain: 24 women took F7 or its modification and 21 were cured (87.50 percent), two improved (8.33 percent) and one did not.